Skip to main content

Lung Density Analysis™ - Inspiration

Multi-purpose analysis tool

LDAi is a fully-automated assessment of areas indicative of emphysema in < 5 minutes, based on a single inspiratory chest CT.

LDAi is validated for use with low-dose CT scans as a component of lung cancer screening programs and includes a patient-centered LungMap™ report to assist with smoking cessation counseling.

FDA 510(k) Cleared, CE Mark Certified, Health Canada Approved

The Power of Personalized Quantitative Imaging

With LDAi, descriptive terminology such as ‘mild’ or ‘moderate’ is no longer acceptable to accurately assess COPD or emphysema.

For Your Practice

LDAi is a fully automated solution delivering quantitative analysis and 3D visualization to the patient study in PACS. LDAi includes Imbio Noise Reduction Technology (NRT) to aid quantification and visualization of low dose scans, and also includes Imbio’s Patient LungMap™ report to aid smoking cessation counseling.

Suggested use cases for LDAi

  • Lung Cancer Screening programs and smoking cessation counseling
  • Population screening for emphysema/COPD on all chest CT scans
  • Patient selection for endobronchial valves
  • Lung Health Programs
  • Clinical Trials